3 transcripts
ACXP
Earnings call transcript
NASDAQ
2024 Q2
9 Aug 24
IIIs today, I'd say we'd still be on target to start, at least piecemeal in the fourth quarter.
Our next question is from the line of James Molloy
ACXP
Earnings call transcript
NASDAQ
2023 Q4
18 Mar 24
of Phase II meeting next month to discuss trial design, patient enrollment targets and to confirm our readiness to go forward.
So to complete our
ACXP
Earnings call transcript
NASDAQ
2023 Q2
14 Aug 23
was very competitive and that their Scientific Advisory Board was enthusiastic about [ pol IIIC ] as the bacterial target of our molecules
- Prev
- 1
- Next